Defects in DNA double‐strand break repair, in particular mutations in genes involved in HR, are associated with an increased risk of cancer, with BRCA1/2 mutations in breast and ovarian cancers being one of the most common examples of this [129, 130]. This evidence concerns the gene BRCA1 and ovarian carcinoma.